Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
Authors:
- Takeshi KajiwaraTKTakeshi Kajiwara
- Tomohiro NishinaTNTomohiro Nishina
- Riu YamashitaRYRiu Yamashita
- Yoshiaki NakamuraYNYoshiaki Nakamura
- Manabu ShiozawaMSManabu Shiozawa
- Satoshi YukiSYSatoshi Yuki
- Hiroya TaniguchiHTHiroya Taniguchi
- Hiroki HaraHHHiroki Hara
- Takashi OhtaTOTakashi Ohta
- Taito EsakiTETaito Esaki
- Eiji ShinozakiESEiji Shinozaki
- Atsuo TakashimaAtsuo Takashima
Open Access
Abstract
The treatment strategies and prognoses of patients with metastatic colorectal cancer (CRC) differ according to the sidedness of the primary tumor. TP53 gain-of-function (GOF) and non-GOF variants have been reported to be differentially associated with prognosis by sidedness. We aimed to evaluate the sidedness-dependent prognostic impact of gene alterations in metastatic CRC. Patients enrolled between April 2017 and March 2019 were included in this study. Those excluded were individuals whose tumor tissues were obtained after chemotherapy and those who were enrolled in the study more than six months after starting first-line chemotherapy. Finally, we assessed 531 patients who underwent complete gene sequencing. The study revealed a significant difference in overall survival between individuals with left-sided CRC (n = 355) and right-sided colon cancer (CC) (n = 176) when considering the TP53 non-GOF variant, KRAS wild-type, NOTCH1 wild-type, NOTCH1 covariant, NOTCH3 sole variant, and MYC amplification. Multivariate analysis on each side revealed that the TP53 GOF and KRAS variants were independent poor prognostic factors for left-sided CRC (p = 0.03 and p < 0.01, respectively), and the TP53 non-GOF variant, BRAF V600E, and MYC amplification for right-sided CC (p < 0.05, p < 0.01, and p = 0.02, respectively). The NOTCH3 sole variant was an independent and favorable prognostic factor for left-sided CRC (p < 0.01). The prognostic significance of gene alterations differed between left-sided CRC and right-sided CC.Keywords
Funding Information
- SCRUM-Japan funds
This publication has 34 references indexed in Scilit:
- Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsAnnals of Oncology, 2017
- Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal CancerJAMA Oncology, 2017
- Prognostic Survival Associated With Left-Sided vs Right-Sided Colon CancerJAMA Oncology, 2017
- The consensus molecular subtypes of colorectal cancerNature Medicine, 2015
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal CancerJNCI: Journal of the National Cancer Institute, 2015
- Nuclear Notch3 Expression is Associated with Tumor Recurrence in Patients with Stage II and III Colorectal CancerAnnals of Surgical Oncology, 2014
- Mutant p53 in Cancer: New Functions and Therapeutic OpportunitiesCancer Cell, 2014
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical UseCold Spring Harbor Perspectives in Biology, 2009